Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
HIV & AIDS
•
Primary Care
Do you routinely prescribe GLP-1 receptor agonists to people living with HIV (PLH) with obesity?
Nguyen Q, et al. PMID 38501237
Related Questions
How do you use CD4% in clinical practice in management of patients living with HIV?
Would you consider using long-acting injectable cabotegravir/rilpivirine for pregnant women with HIV?
What is your approach to a positive PPD or IGRA in a patient with well-controlled HIV without significant TB risk factors?
How do you approach management for patient's with HIV on ART with persistent low level viremia but no new resistance mutations identified?
What steps do you recommend to ensure continued viral suppression and prevent drug resistance in an HIV patient on injectable cabotegravir and rilpivirine who misses their scheduled injection appointment by two weeks?
In what situations would you use "direct-to-inject" ART, such as Cabenuva, without an oral lead-in?
How would you manage a patient with progressive/refractory molluscum contagiosum who is well controlled on methotrexate for seropositive rheumatoid arthritis?
When do you recommend limited or targeted respiratory pathogen testing versus a full respiratory pathogen panel in a patient presenting with URI symptoms?
Would you recommend switching from an integrase strand transfer inhibitor-based regimen to a different antiretroviral regimen, or would you instead add weight loss medications for a person with HIV experiencing weight gain that has not improved with lifestyle changes?
Do you routinely use oral vancomycin prophylaxis in patients with a history of CDI who are receiving antibiotics?
